YU40787A - Postupak za dobijanje čvrstog preparata sa produženim oslobađanjem aktivnog jedinjenja - Google Patents

Postupak za dobijanje čvrstog preparata sa produženim oslobađanjem aktivnog jedinjenja

Info

Publication number
YU40787A
YU40787A YU40787A YU40787A YU40787A YU 40787 A YU40787 A YU 40787A YU 40787 A YU40787 A YU 40787A YU 40787 A YU40787 A YU 40787A YU 40787 A YU40787 A YU 40787A
Authority
YU
Yugoslavia
Prior art keywords
active compound
extended release
procedure
obtaining
solid preparation
Prior art date
Application number
YU40787A
Other languages
English (en)
Other versions
YU47258B (sh
Inventor
K.E.L. Falk
S.M. Hugosson
A. Rosinski
J.A. Sjoegren
Original Assignee
Aktiebolaget Haessle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20364135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU40787(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aktiebolaget Haessle filed Critical Aktiebolaget Haessle
Priority to SI8710407A priority Critical patent/SI8710407B/sl
Publication of YU40787A publication Critical patent/YU40787A/sh
Priority to HRP-407/87A priority patent/HRP920630B1/xx
Publication of YU47258B publication Critical patent/YU47258B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

POSTUPAK ZA DOBIJANJE ČVRSTOG PREPARATA SA PRODUŽENIM OSLOBAĐANJEM AKTIVNOG JEDINJENJA sa vrlo niskom rastvorljivošću koji sadrži aktivno jedinjenje rastvoreno ili dispergovano u polu-čvrstom ili tečnom ne-jonskom sredstvu za rastvaranje, pri čemu je masena količina sredstva za rastvaranje bar jednaka masenoj količini aktivnog jedinjenja, kao i postupak za njegovo dobijanje.
YU40787A 1986-04-11 1987-03-12 Postupak za dobijanje čvrstog preparata sa produženim oslobadjanjem aktivnog jedinjenja YU47258B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8710407A SI8710407B (sl) 1986-04-11 1987-03-12 Postopek za pridobivanje trdnega pripravka s podaljšanim sproščanjem aktivne spojine
HRP-407/87A HRP920630B1 (en) 1986-04-11 1992-09-30 New pharmaceutical preparations having extended delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601624A SE8601624D0 (sv) 1986-04-11 1986-04-11 New pharmaceutical preparations

Publications (2)

Publication Number Publication Date
YU40787A true YU40787A (sh) 1992-09-07
YU47258B YU47258B (sh) 1995-01-31

Family

ID=20364135

Family Applications (1)

Application Number Title Priority Date Filing Date
YU40787A YU47258B (sh) 1986-04-11 1987-03-12 Postupak za dobijanje čvrstog preparata sa produženim oslobadjanjem aktivnog jedinjenja

Country Status (34)

Country Link
US (1) US4803081A (sh)
EP (1) EP0249587B1 (sh)
JP (1) JPH0778016B2 (sh)
KR (2) KR870009720A (sh)
CN (1) CN1025150C (sh)
AT (1) ATE76288T1 (sh)
AU (1) AU602677B2 (sh)
CA (1) CA1304294C (sh)
CS (1) CS270560B2 (sh)
CY (1) CY1826A (sh)
DD (1) DD263231A5 (sh)
DE (1) DE3779183D1 (sh)
DK (1) DK173033B1 (sh)
DZ (1) DZ1067A1 (sh)
EG (1) EG18265A (sh)
ES (1) ES2031929T3 (sh)
FI (1) FI91826C (sh)
GR (1) GR3005286T3 (sh)
HK (1) HK26795A (sh)
HU (1) HU204699B (sh)
IE (1) IE59419B1 (sh)
IS (1) IS1553B (sh)
MY (1) MY101553A (sh)
NO (1) NO174795B (sh)
NZ (1) NZ219633A (sh)
PH (1) PH22494A (sh)
PL (1) PL265078A1 (sh)
PT (1) PT84663B (sh)
SE (1) SE8601624D0 (sh)
SG (1) SG4295G (sh)
SU (1) SU1743332A3 (sh)
UA (1) UA12336A (sh)
YU (1) YU47258B (sh)
ZA (1) ZA871911B (sh)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5006344A (en) * 1989-07-10 1991-04-09 E. R. Squibb & Sons, Inc. Fosinopril tablet formulations
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
JPH07502274A (ja) * 1991-12-10 1995-03-09 ラシユ−プレスビタリアン−セントルークス・メデイカル・センター 多薬剤耐性を低下させる方法および組成物
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
PT661045E (pt) * 1992-09-18 2002-11-29 Yamanouchi Pharma Co Ltd Preparacao em hidrogel de libertacao prolongada
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
IL130797A0 (en) 1997-01-30 2001-01-28 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion
JP3893058B2 (ja) * 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー 高度に可溶性の薬物のための徐放性マトリックス系
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
HUP0300444A3 (en) * 2000-04-11 2007-09-28 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
SE0004671D0 (sv) * 2000-12-15 2000-12-15 Amarin Dev Ab Pharmaceutical formulation
WO2002056883A1 (en) * 2001-01-18 2002-07-25 Wockhardt Limited Preparation of micron-size felodipine particles by microfluidization
WO2003004032A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
CN1592611A (zh) * 2001-09-28 2005-03-09 麦克内尔-Ppc股份有限公司 改良释放的剂型
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
US6726931B2 (en) * 2002-04-08 2004-04-27 Standard Chem. & Pharm. Co., Ltd. Process for preparing oral sustained-release formulation of felodipine
CA2480824A1 (fr) 2002-04-09 2003-10-16 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
US20030211149A1 (en) * 2002-05-07 2003-11-13 Sherman Bernard Charles Extended release tablets comprising felodipine
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20060134196A1 (en) * 2002-12-17 2006-06-22 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8987322B2 (en) * 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
US11311490B2 (en) * 2005-08-10 2022-04-26 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
CN101103964B (zh) * 2006-07-14 2010-09-29 海南盛科生命科学研究院 一种含有非洛地平的缓释制剂及其制备方法
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US9419566B2 (en) 2011-04-20 2016-08-16 Freescale Semiconductor, Inc. Amplifiers and related integrated circuits
CN104997750B (zh) * 2015-07-30 2018-03-20 杭州康恩贝制药有限公司 一种非洛地平缓释片及其制备方法
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
CN109200026B (zh) * 2017-07-03 2021-01-05 北京四环科宝制药有限公司 一种非洛地平缓释片及其制备方法
AU2019285170A1 (en) 2018-06-14 2021-01-28 Astrazeneca Uk Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
JPS5495721A (en) * 1978-01-11 1979-07-28 Nippon Kayaku Co Ltd Nifedipine preparation
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS58109412A (ja) * 1981-12-23 1983-06-29 Toa Eiyou Kagaku Kogyo Kk ニフエジピン固形製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Also Published As

Publication number Publication date
YU47258B (sh) 1995-01-31
HK26795A (en) 1995-03-10
DD263231A5 (de) 1988-12-28
NO871199L (no) 1987-10-12
PH22494A (en) 1988-09-12
HU204699B (en) 1992-02-28
IS3214A7 (is) 1987-10-12
US4803081A (en) 1989-02-07
ZA871911B (en) 1987-12-30
HUT43786A (en) 1987-12-28
FI871585A (fi) 1987-10-12
DK154987A (da) 1987-10-12
CN1025150C (zh) 1994-06-29
MY101553A (en) 1991-12-17
IE59419B1 (en) 1994-02-23
SG4295G (en) 1995-06-16
SU1743332A3 (ru) 1992-06-23
SE8601624D0 (sv) 1986-04-11
NO174795B (no) 1994-04-05
PT84663A (en) 1987-05-01
CA1304294C (en) 1992-06-30
NO174795C (sh) 1994-07-13
JPS62242613A (ja) 1987-10-23
UA12336A (uk) 1996-12-25
EG18265A (en) 1992-12-30
AU602677B2 (en) 1990-10-25
FI871585A0 (fi) 1987-04-10
PL265078A1 (en) 1988-07-21
FI91826B (fi) 1994-05-13
IS1553B (is) 1994-08-10
EP0249587B1 (en) 1992-05-20
KR870009720A (ko) 1987-11-30
IE870925L (en) 1987-10-11
NZ219633A (en) 1989-11-28
JPH0778016B2 (ja) 1995-08-23
FI91826C (fi) 1994-08-25
GR3005286T3 (sh) 1993-05-24
CY1826A (en) 1995-12-01
PT84663B (pt) 1989-11-30
DK154987D0 (da) 1987-03-26
NO871199D0 (no) 1987-03-23
ATE76288T1 (de) 1992-06-15
AU7004387A (en) 1987-10-15
DE3779183D1 (de) 1992-06-25
ES2031929T3 (es) 1993-01-01
KR950002147B1 (ko) 1995-03-14
DZ1067A1 (fr) 2004-09-13
KR890001521A (ko) 1989-03-27
CS270560B2 (en) 1990-07-12
EP0249587A1 (en) 1987-12-16
CS258787A2 (en) 1989-11-14
CN87102758A (zh) 1987-10-21
DK173033B1 (da) 1999-11-29

Similar Documents

Publication Publication Date Title
YU40787A (sh) Postupak za dobijanje čvrstog preparata sa produženim oslobađanjem aktivnog jedinjenja
DE3382637D1 (de) Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES2041249T3 (es) Preparaciones liquidas de 1,2-benzoisotiazolin-3-ona, su obtencion y empleo.
ATE84209T1 (de) Hautreinigungsmittel.
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ATE117313T1 (de) Stabile lösungen von rebeccamycinderivaten sowie deren herstellung.
DK486879A (da) Fremgangsmaade til fremstilling af aminopropanolderivater af 6-hydroxy-2,3,4,5-tetrahydro-1h-1-benzazepin-2-on eller syreadditionssalte deraf
TH2909A (th) องค์ประกอบสำหรับสิ่งที่ใช้ภายในปากและวิธีทำให้สารออกฤทธิ์คงตัวอยู่ภายในองค์ประกอบสำหรับสิ่งที่ใช้ภายในปาก
TH2909EX (th) องค์ประกอบสำหรับสิ่งที่ใช้ภายในปากและวิธีทำให้สารออกฤทธิ์คงตัวอยู่ภายในองค์ประกอบสำหรับสิ่งที่ใช้ภายในปาก
CS274751B2 (en) Agent for plants' medium stress factors effects protection